Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |